Linezolid for the treatment of Nocardia spp. infections

Annals of Pharmacotherapy

Volumn 41, Issue 10, 2007, Pages 1694-1699

  Jodlowski, Tomasz Z ^a,b   Melnychuk, Igor ^c   Conry, John ^a  

^a ST JOHN'S UNIVERSITY   (United States)

^b JACOBI MEDICAL CENTER   (United States)

^c Baptist Medical Center Beaches   (United States)

Author keywords

Linezolid; Nocardia

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; IMIPENEM; LINEZOLID; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANEMIA; BACTERIUM ISOLATION; BONE MARROW SUPPRESSION; COCHRANE LIBRARY; COMORBIDITY; DISEASE COURSE; DRUG WITHDRAWAL; HUMAN; LACTIC ACIDOSIS; MEDLINE; MINIMUM INHIBITORY CONCENTRATION; NOCARDIA ASTEROIDES; NOCARDIOSIS; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SCISEARCH; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE;

ACETAMIDES; ANIMALS; HUMANS; NOCARDIA; NOCARDIA INFECTIONS; OXAZOLIDINONES; RETROSPECTIVE STUDIES;

EID: 34748877133     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K196     Document Type: Review

References (25)

1. Sorrell TC, Mitchell DH, Iredell JR. Nocardia species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. New York: Elsevier, 2005:2916-24.
2. Fleetwood IG, Embil JM, Ross IB. Nocardia asteroides abscesses in IC hosts: report of three cases and review of surgical recommendations. Surg Neurol 2000;53:605-10.
3. Lerner PI. Nocardiosis. Clin Infect Dis 1996;22:891-905.
4. Moylett EH, Pacheco SE, Brown-Elliott BA, et al. Clinical experience with linezolid for the treatment of Nocardia infection. Clin Infect Dis 2003;36:313-8.
5. Package insert. Zyvox (linezolid). New York: Pharmacia and Upjohn, Division of Pfizer, July 2006.
6. Brown-Elliot BA, Ward SC, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother 2001;45:1295-7.
7. Glupczynski Y, Berhin C, Janssens M, Wauters G. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect 2006;12:905-12.
8. Vera-Cabrera L, Gomez-Flores A, Escalante-Fuentes WG, Welsh O. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial against Nocardia brasiliensis. Antimicrob Agents Chemother 2001;45:3629-30.
9. Lewis KE, Ebden P, Wooster SL, Rees J, Harrison GA. Multi-system infection with Nocardia farcinica-therapy with linezolid and minocycline. J Infect 2003;46:199-202.
10. Moitra RK, Auckland C, Cawley M, et al. Systemic nocardiosis in a splenectomized patient with systemic lupus erythematosus: successful treatment using linezolid. J Clin Rheumatol 2003;9:47-50.
11. Rupprecht TA, Pfister HW. Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol 2005;12:536-42.
12. Vigano SM, Edefonti A, Ferraresso M, et al. Successful medical treatment of multiple abscesses due to Nocardia farcinica in pediatric renal transplant recipient. Pediatr Nephrol 2005:20:1186-8.
13. Justiniano M, Glorioso S, Dold S, Espinoza LR. Nocardia brain abscesses in a male patient with SLE: successful outcome despite delay in diagnosis. Clin Rheumatol 2007;26:1020-2.
14. Villani P, Regazzi MB, Marubbi F, et al. Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother 2002;46:936-7.
15. Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007:41:296-308. Epub 6 Feb 2007. DOI 10.1345/aph.1H307
16. Huang V, Gortney JS. Risk of Serotonin syndrome with concomitant administration of linezolid and serotonin agonists. Pharmacotherapy 2006;26:1784-93.
17. Taylor JJ, Wilson JW, Estes LL. Linezolid and serotonergic drug interactions: a retrospective survey. Clin Infect Dis 2006;43:180-7.
18. Lawrence KR, Adra M, Gillman PK. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clin Infect Dis 2006;42:1578-83.
19. Bergeron L, Boulé M, Perreault S. Serotonin toxicity associated with concomitant use of linezolid. Ann Pharmacother 2005;39:956-61. Epub 12 Apr 2005. DOI 10.1345/aph.1E523
20. Lee E, Burger S, Shah J, Melton C, et al. Linezolid-associated toxic optic neuropathy: a report of 2 cases. Clin Infect Dis 2003;37:1389-91.
21. Saijo T, Hayashi K, Yamada H, Wakakura M. Linezolid-induced optic neuropathy. Am J Ophthamol 2005;139:1114-6.
22. Bressler AM, Zimmer SM, Gilmore JL, Somani J. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 2004;4:528-31.
23. Rho JP, Sia IG, Cram BA, Dekutoski MB, Trousdale RT. Linezolid-associated peripheral neuropathy. Mayo Clin Proc 2004;79:927-30.
24. Spellberg B, Yoo T, Bayer AS. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6. J Antimicrob Chemother 2004;54:832-5.
25. Plachouras D, Giannitsioti E, Athanassia S. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment. Clin Infect Dis 2006;43:89-91.